Clorox (NYSE:CLX – Get Free Report) had its price objective decreased by equities researchers at Wells Fargo & Company from $102.00 to $90.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s target price would suggest a potential upside of 4.22% from the company’s current price.
Other equities analysts have also recently issued reports about the stock. Wall Street Zen cut shares of Clorox from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Evercore set a $99.00 target price on shares of Clorox in a research report on Tuesday, August 4th. Jefferies Financial Group cut shares of Clorox from a “buy” rating to a “hold” rating and decreased their target price for the stock from $125.00 to $98.00 in a research note on Tuesday, July 28th. Citigroup upped their price target on shares of Clorox from $97.00 to $100.00 and gave the stock a “neutral” rating in a report on Tuesday, August 4th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research note on Friday, July 10th. Twelve equities research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat, Clorox has an average rating of “Reduce” and an average target price of $101.60.
Clorox Price Performance
Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, topping the consensus estimate of $1.64 by $0.02. The firm had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The business’s quarterly revenue was down 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.87 earnings per share. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, analysts anticipate that Clorox will post 5.8 EPS for the current fiscal year.
Institutional Investors Weigh In On Clorox
A number of institutional investors have recently added to or reduced their stakes in CLX. Miramontes Capital LLC acquired a new position in Clorox in the 2nd quarter valued at approximately $319,000. Tidal Investments LLC lifted its holdings in shares of Clorox by 26.4% during the second quarter. Tidal Investments LLC now owns 38,464 shares of the company’s stock worth $3,671,000 after purchasing an additional 8,031 shares during the period. National Pension Service lifted its holdings in shares of Clorox by 29.7% during the second quarter. National Pension Service now owns 31,827 shares of the company’s stock worth $3,038,000 after purchasing an additional 7,291 shares during the period. RFG Advisory LLC grew its stake in shares of Clorox by 7.3% in the second quarter. RFG Advisory LLC now owns 3,418 shares of the company’s stock worth $326,000 after purchasing an additional 232 shares during the last quarter. Finally, NewEdge Advisors LLC grew its stake in shares of Clorox by 11.8% in the second quarter. NewEdge Advisors LLC now owns 75,135 shares of the company’s stock worth $7,171,000 after purchasing an additional 7,956 shares during the last quarter. 78.53% of the stock is owned by institutional investors.
About Clorox
The Clorox Company (NYSE: CLX) is a consumer products company that develops, manufactures and markets household, health and wellness, and lifestyle products. Its portfolio includes cleaning and disinfecting products, laundry and home-care items, food products, personal-care products, water-filtration systems, charcoal, and cat litter.
Clorox’s brands include Clorox bleach and disinfecting products, Pine-Sol, Fresh Step and Scoop Away, Kingsford, Brita, Burt’s Bees, Hidden Valley, and products marketed under the Glad name.
Read More
- Five stocks we like better than Clorox
- This AI ETF Is Missing the Biggest AI Winners
- Could Snowflake’s Big Quarter Be a Sign of More to Come?
- Microsoft’s Azure Reporting Shift Adds Clarity, But the Bull Case Came First
- Feed to Feat: Can Meta Unlock the AI Agent Cash Machine?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
